Scholarlink

Background <p>Nanotechnology has revolutionized medicine by providing innovative solutions for the diagnosis, treatment, and prevention of diseases. Silver nanoparticles (AgNPs) and aluminum hydroxide nanoparticles (Al(OH)<sub>3</sub> NPs) are commonly used due to their antimicrobial and vaccine-adjuvant properties. However, their potential toxicity and safety concerns have raised questions regarding their responsible application.</p> Methods <p>This study evaluated the potential histopathological and genotoxic effects of AgNPs and Al(OH)<sub>3</sub> NPs on mouse livers. Fifty young CD-1 male albino mice were classified into five groups: control, AgNPs (5 and 10 mg/kg), and Al(OH)<sub>3</sub> NPs (5 and 10 mg/kg). AgNPs were administered for 5 consecutive days/week for 4 weeks, while Al(OH)<sub>3</sub> NPs were administered once/week for 4 weeks.</p> Results <p>Both AgNPs and Al(OH)<sub>3</sub> NPs induced histopathological changes, including focal infiltration, vacuolar degeneration, and congestion in the portal blood vessels and central vein. The comet assay results showed significant DNA damage in all treated groups, with high doses of AgNPs (10 mg/kg) exhibiting severe DNA damage (grade 3) in 9.33% of liver cells. DNA fragmentation results demonstrated a highly significant increase in DNA fragmentation and aggregation in both the high- and low-dose groups.</p> Conclusion <p>These findings highlight the importance of using AgNPs and Al(OH)<sub>3</sub> NPs safely and responsibly in medicine and emphasize the need for further research on their potential toxicity and mechanisms of action. The results of this study contribute to the existing literature on evidence of nanoparticle safety and highlight the need for stringent regulatory guidelines to mitigate potential health risks.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparative analysis of silver and aluminum hydroxide nanoparticle-induced hepatotoxicity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月20日

查看全文
  • Nagla Zaky Ibrahim El-Alfy,
  • Sally Ramadan Gabr Eid El-Ashry,
  • Mahmoud Fathy Mahmoud,
  • Eman Saad Abd Elhady,
  • Asmaa Ahmed Khaled Emam

摘要

Background

Nanotechnology has revolutionized medicine by providing innovative solutions for the diagnosis, treatment, and prevention of diseases. Silver nanoparticles (AgNPs) and aluminum hydroxide nanoparticles (Al(OH)3 NPs) are commonly used due to their antimicrobial and vaccine-adjuvant properties. However, their potential toxicity and safety concerns have raised questions regarding their responsible application.

Methods

This study evaluated the potential histopathological and genotoxic effects of AgNPs and Al(OH)3 NPs on mouse livers. Fifty young CD-1 male albino mice were classified into five groups: control, AgNPs (5 and 10 mg/kg), and Al(OH)3 NPs (5 and 10 mg/kg). AgNPs were administered for 5 consecutive days/week for 4 weeks, while Al(OH)3 NPs were administered once/week for 4 weeks.

Results

Both AgNPs and Al(OH)3 NPs induced histopathological changes, including focal infiltration, vacuolar degeneration, and congestion in the portal blood vessels and central vein. The comet assay results showed significant DNA damage in all treated groups, with high doses of AgNPs (10 mg/kg) exhibiting severe DNA damage (grade 3) in 9.33% of liver cells. DNA fragmentation results demonstrated a highly significant increase in DNA fragmentation and aggregation in both the high- and low-dose groups.

Conclusion

These findings highlight the importance of using AgNPs and Al(OH)3 NPs safely and responsibly in medicine and emphasize the need for further research on their potential toxicity and mechanisms of action. The results of this study contribute to the existing literature on evidence of nanoparticle safety and highlight the need for stringent regulatory guidelines to mitigate potential health risks.